CLINICAL_TRIALS
trial_result
· 2025-04-29
Clinical Trial Update: Scopolamine in Bipolar Depression [Phase 2]
Summary
A Phase 2 clinical trial evaluating scopolamine for bipolar depression has completed, with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Dr. Brian Hallahan | Conditions: Bipolar Disorder Depression | Phase 2 | Status: COMPLETED | Results posted: 2025-04-29